| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.50B | +2.5% | +9.2% |
| Cost of Revenue | $840.7M | +3.2% | +10.6% |
| Gross Profit | $655.5M | +1.5% | +7.4% |
| R&D Expense | $29.5M | +4.6% | +7.8% |
| SG&A Expense | $352.3M | +0.7% | +5.0% |
| Operating Income | $273.2M | +2.8% | +11.4% |
| Pre-tax Income | $257.8M | +1.9% | +12.7% |
| Income Tax | $63.5M | +4.8% | +14.7% |
| Net Income | $192.9M | +0.5% | +11.2% |
| EPS (Basic) | $1.96 | +0.5% | +11.4% |
| EPS (Diluted) | $1.96 | +1.0% | +12.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $423.7M | +32.7% | +173.0% |
| Accounts Receivable | $990.6M | +4.6% | +8.2% |
| Inventory | $673.5M | +2.3% | +3.7% |
| Current Assets | $2.29B | +8.5% | +20.5% |
| Total Assets | $10.59B | +1.7% | +5.8% |
| Current Liabilities | $922.3M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.01B | — | — |
| Capital Expenditures | $278.8M | — | — |
| Investing Cash Flow | -$295.3M | — | — |
| Financing Cash Flow | -$470.3M | — | — |
| Free Cash Flow | $727.2M | — | — |
| +3.5% |
| Long-term Debt | $1.90B | +0.1% | -6.9% |
| Total Liabilities | $3.42B | +1.0% | -4.4% |
| Stockholders' Equity | $7.15B | +2.1% | +11.5% |